Your browser doesn't support javascript.
loading
Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Bonnefoi, Hervé; Potti, Anil; Delorenzi, Mauro; Mauriac, Louis; Campone, Mario; Tubiana-Hulin, Michèle; Petit, Thierry; Rouanet, Philippe; Jassem, Jacek; Blot, Emmanuel; Becette, Véronique; Farmer, Pierre; André, Sylvie; Acharya, Chaitanya R; Mukherjee, Sayan; Cameron, David; Bergh, Jonas; Nevins, Joseph R; Iggo, Richard D.
Afiliación
  • Bonnefoi H; Geneva University Hospital, Geneva, Switzerland; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland. Electronic address: bonnefoi@bergonie.org.
  • Potti A; Duke Institute for Genome Sciences and Policy, and Duke University Medical Center, Durham, NC, USA.
  • Delorenzi M; Swiss Institute for Experimental Cancer Research (ISREC), National Centre of Competence in Research (NCCR), Epalinges, Switzerland; Swiss Institute for Bioinformatics (SIB), Lausanne, Switzerland.
  • Mauriac L; Bergonié Institute, Bordeaux, France.
  • Campone M; René Gauducheau Centre, Nantes, France.
  • Tubiana-Hulin M; René Huguenin Centre, St-Cloud, France.
  • Petit T; Paul Strauss Centre, Strasbourg, France.
  • Rouanet P; Paul Lamarque Centre, Montpellier, France.
  • Jassem J; Medical University, Gdansk, Poland.
  • Blot E; Henri Becquerel Centre, Rouen, France.
  • Becette V; René Huguenin Centre, St-Cloud, France.
  • Farmer P; Swiss Institute for Experimental Cancer Research (ISREC), National Centre of Competence in Research (NCCR), Epalinges, Switzerland; Swiss Institute for Bioinformatics (SIB), Lausanne, Switzerland.
  • André S; Swiss Institute for Experimental Cancer Research (ISREC), National Centre of Competence in Research (NCCR), Epalinges, Switzerland.
  • Acharya CR; Duke Institute for Genome Sciences and Policy, and Duke University Medical Center, Durham, NC, USA.
  • Mukherjee S; Duke Institute for Genome Sciences and Policy, and Duke University Medical Center, Durham, NC, USA.
  • Cameron D; Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh University, Edinburgh, UK.
  • Bergh J; Swedish Breast Cancer Group (SweBCG), Karolinska Institute and Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden.
  • Nevins JR; Duke Institute for Genome Sciences and Policy, and Duke University Medical Center, Durham, NC, USA.
  • Iggo RD; Swiss Institute for Experimental Cancer Research (ISREC), National Centre of Competence in Research (NCCR), Epalinges, Switzerland; University of St Andrews, Scotland, UK.
Lancet Oncol ; 8(12): 1071-1078, 2007 Dec.
Article en En | MEDLINE | ID: mdl-18024211

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Regulación Neoplásica de la Expresión Génica / Pruebas Genéticas / Selección de Paciente / Análisis de Secuencia por Matrices de Oligonucleótidos / Perfilación de la Expresión Génica Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2007 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Regulación Neoplásica de la Expresión Génica / Pruebas Genéticas / Selección de Paciente / Análisis de Secuencia por Matrices de Oligonucleótidos / Perfilación de la Expresión Génica Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2007 Tipo del documento: Article Pais de publicación: Reino Unido